Oliver S. Chow

Effect of adding mFOLFOX6 after neoadjuvant chemoradiation in locally advanced rectal cancer: a multicentre, phase 2 trial

Julio García‐Aguilar, Oliver S. Chow, David Smith et al. · The Lancet Oncology · 2015 · 698 citations · Full text

Medicine, Oncology, Chemotherapy +15

Assessment of a Watch-and-Wait Strategy for Rectal Cancer in Patients With a Complete Response After Neoadjuvant Therapy

J. Joshua Smith, Paul Strombom, Oliver S. Chow et al. · JAMA Oncology · 2019 · 594 citations · Full text

Medicine, Oncology, Surgery +15

Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial

Julio García‐Aguilar, Lindsay A. Renfro, Oliver S. Chow et al. · The Lancet Oncology · 2015 · 424 citations · Full text

Medicine, Oncology, Surgery +17

Organ Preservation in Rectal Adenocarcinoma: a phase II randomized controlled trial evaluating 3-year disease-free survival in patients with locally advanced rectal cancer treated with chemoradiation plus induction or consolidation chemotherapy, and total mesorectal excision or nonoperative management

J. Joshua Smith, Oliver S. Chow, Marc J. Gollub et al. · BMC Cancer · 2015 · 387 citations · Full text

Medicine, Radiation Oncology, Gastrointestinal Oncology +16

Genomic and transcriptomic determinants of response to neoadjuvant therapy in rectal cancer

Walid K. Chatila, Jin K. Kim, Henry Walch et al. · Nature Medicine · 2022 · 149 citations · Full text

Medicine, Bioinformatics, Oncology +16